- Main
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion
- Elliott, Irmina A;
- Dann, Amanda M;
- Xu, Shili;
- Kim, Stephanie S;
- Abt, Evan R;
- Kim, Woosuk;
- Poddar, Soumya;
- Moore, Alexandra;
- Zhou, Lei;
- Williams, Jennifer L;
- Capri, Joseph R;
- Ghukasyan, Razmik;
- Matsumura, Cynthia;
- Tucker, D Andrew;
- Armstrong, Wesley R;
- Cabebe, Anthony E;
- Wu, Nanping;
- Li, Luyi;
- Le, Thuc M;
- Radu, Caius G;
- Donahue, Timothy R
- et al.
Published Web Location
https://doi.org/10.1073/pnas.1812410116Abstract
Functional lysosomes mediate autophagy and macropinocytosis for nutrient acquisition. Pancreatic ductal adenocarcinoma (PDAC) tumors exhibit high basal lysosomal activity, and inhibition of lysosome function suppresses PDAC cell proliferation and tumor growth. However, the codependencies induced by lysosomal inhibition in PDAC have not been systematically explored. We performed a comprehensive pharmacological inhibition screen of the protein kinome and found that replication stress response (RSR) inhibitors were synthetically lethal with chloroquine (CQ) in PDAC cells. CQ treatment reduced de novo nucleotide biosynthesis and induced replication stress. We found that CQ treatment caused mitochondrial dysfunction and depletion of aspartate, an essential precursor for de novo nucleotide synthesis, as an underlying mechanism. Supplementation with aspartate partially rescued the phenotypes induced by CQ. The synergy of CQ and the RSR inhibitor VE-822 was comprehensively validated in both 2D and 3D cultures of PDAC cell lines, a heterotypic spheroid culture with cancer-associated fibroblasts, and in vivo xenograft and syngeneic PDAC mouse models. These results indicate a codependency on functional lysosomes and RSR in PDAC and support the translational potential of the combination of CQ and RSR inhibitors.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-